Gas Gangrene 

  • Author: Hoi Ho, MD; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Aug 16, 2011
 

Background

Gas gangrene and clostridial myonecrosis are interchangeable terms used to describe an infection of muscle tissue by toxin-producing clostridia. In 1861, Louis Pasteur identified the first clostridial species, Clostridium butyricum. In 1892 and later, Welch, Nuttall, and other scientists isolated a gram-positive anaerobic bacillus from gangrenous wounds. This organism, originally known as Bacillus aerogenes capsulatus, was later renamed Bacillus perfringens, and then Clostridium welchii. The organism is now named Clostridium perfringens.

Gas gangrene gained recognition for its wartime incidence, during which only a paucity of civilian cases occurred. During World War I, gas gangrene complicated 6% of open fractures and 1% of all open wounds. These figures steadily decreased to 0.7% during World War II, 0.2% during the Korean War, and 0.002% during the Vietnam War. No cases of gas gangrene were reported during the battle in the Falkland Islands in 1982.[1]

Despite numerous casualties caused by enormous firepower and improvised explosive devices (IEDs), no cases of gas gangrene have been reported among US soldiers during the ongoing operation Iraqi Freedom. The lethality of war wounds has decreased from 24% during operation Desert Storm (1991) to an unprecedented 10% during operation Iraqi Freedom. The US military medicine has credited this to the mobility of the forward surgical teams (FSTs) in keeping up with the fast-moving military units.[2, 3, 4]

The incidence of gas gangrene was 0.96% in a study of 1970 survivors admitted to Sichuan Provincial People’s Hospital after the 2008 Wenchuan earthquake.[5]

Next

Pathophysiology

Gas gangrene is caused by an anaerobic, gram-positive, spore-forming bacillus of the genus Clostridium. C perfringens is the most common etiologic agent that causes gas gangrene. Other common clostridial species that cause gas gangrene include Clostridium bifermentans, Clostridium septicum, Clostridium sporogenes, Clostridium novyi, Clostridium fallax, Clostridium histolyticum, and Clostridium tertium.[6]

These organisms are true saprophytes and are ubiquitous in soil and dust. Clostridia have been isolated from the mucous membranes of humans, including the GI tract and the female genital tract. Clostridia may also colonize the skin, especially around the perineum. Clostridia are obligate anaerobes, but some species are relatively aerotolerant. Bacterial multiplication and the production of soluble proteins called exotoxins require a low oxygen tension.

Other bacteria are also capable of producing gas, and nonclostridial organisms have been isolated in 60-85% cases of gas gangrene. A recent clinical series on gas gangrene demonstrated a predominance (83.3%) of aerobic gram-negative bacilli in wound cultures compared with anaerobic gram-positive bacilli, with Clostridium species accounting for 4.5% of the isolates. The most frequently identified aerobic gram-negative bacteria were Escherichia coli,Proteus species, Pseudomonas aeruginosa, and Klebsiella pneumoniae.[6, 7, 8]

C perfringens produces at least 20 exotoxins. The most important exotoxins and their biologic effects are as follows:

  • Alpha toxin - Lethal,* lecithinase, necrotizing, hemolytic, cardiotoxic
  • Beta toxin - Lethal,* necrotizing
  • Epsilon toxin - Lethal,* permease
  • Iota toxin - Lethal,* necrotizing
  • Delta toxin - Lethal,* hemolysin
  • Phi toxin - Hemolysin, cytolysin
  • Kappa toxin - Lethal,* collagenase, gelatinase, necrotizing
  • Lambda toxin - Protease
  • Mu toxin - Hyaluronidase
  • Nu toxin - Lethal,* deoxyribonuclease, hemolytic, necrotizing
  • *Lethal as tested by injection in mice

Significant variance exists among clostridial species as to the mechanism of action of the alpha toxin. In C septicum, the alpha toxin forms pores and induces necrosis by causing the rapid loss of intracellular potassium and depletion of adenosine triphosphate (ATP). Strains that do not produce alpha-toxin are less virulent, underscoring its importance.[9] In mice models, alpha-toxin–induced lethality was inhibited by the preadministration of erythromycin. Erythromycin resulted in a reduction of the release of cytokines tumor necrosis factor-alpha (TNF-alpha), interleukin 1, and interleukin 6. Additionally, TNF-alpha–deficient mice were resistant to C perfringens alpha-toxin, suggesting that TNF-alpha is an important contributor to the toxic effects of clostridial proteins.[10]

Genetic regulation of clostridial cytotoxic exotoxin production is under the control of several different regulatory systems, including the global VirR/VirS 2-component signal transduction system, and the RevR. The VirR, a membrane bound external sensor, and the VirS, a gene response regulator, together transmit and receive signals from the environment to the inside of the cell. The VirR/VirS system uses RNA intermediates to control 147 distinct genes and their associated operons.[11]

The phi-toxin is a hemolysin. Although it does not directly suppress myocardial function in vitro, it contributes to myocardial suppression in vivo, possibly by increasing the synthesis of secondary mediators that do suppress myocardial function in vitro. At higher concentrations, the phi-toxin can cause extensive cellular degeneration and direct vascular injury.

The kappa-toxin produced by C perfringens is a collagenase responsible for destruction of blood vessels and connective tissue. Other toxins include a deoxyribonuclease and hyaluronidase.

Contamination with clostridial spores in posttraumatic or postoperative lesions establishes the initial stage of infection. Local wound conditions are more important than the degree of clostridial contamination in the development of gas gangrene. Disrupted or necrotic tissue provides the necessary enzymes and a low oxidation/reduction potential, allowing for spore germination. Foreign bodies, premature wound closure, and devitalized muscle reduce the spore inoculum necessary to cause infection in laboratory animals.

The typical incubation period for gas gangrene is frequently short (ie, < 24 h), but incubation periods of 1 hour to 6 weeks have been reported. Self-perpetuating destruction of tissue occurs via a rapidly multiplying microbial population and the production of locally and systemically acting exotoxins. Local effects include necrosis of muscle and subcutaneous fat and thrombosis of blood vessels. Marked edema may further compromise blood supply to the region. Fermentation of glucose is probably the main mechanism of gas production in gas gangrene. In C septicum spontaneous gas gangrene, nitrogen is the predominant gas component (74.5%), followed by oxygen (16.1%), hydrogen (5.9%), and carbon dioxide (3.4%). Production of hydrogen sulfide and carbon dioxide gas begins late and dissects along muscle bellies and fascial planes. These local effects create an environment that facilitates rapid spread of the infection.[12]

Systemically, exotoxins may cause severe hemolysis. Hemoglobin levels may drop to very low levels and, when occurring with hypotension, may cause acute tubular necrosis and renal failure. A rapidly progressive infection can quickly result in shock. The mechanism of shock is poorly understood. Unconcentrated filtrate from C perfringens, purified alpha-toxin, and purified phi-toxins cause hypotension, bradycardia, and decreased cardiac output when injected into laboratory animals. Because alpha-toxins and phi-toxins are lipophilic and may remain locally bound to tissue plasma membranes, the toxins may stimulate synthesis of secondary mediators that cause cardiovascular abnormalities.

Previous
Next

Epidemiology

Frequency

United States

Clostridia species are ubiquitous and widely distributed in the soil, especially in cultivated land. The density of clostridia in the soil is a contributing factor in the development of trauma-related gas gangrene. Civilian cases of gas gangrene are more common, with approximately 3000 cases per year. Gas gangrene can be classified as posttraumatic, postoperative, or spontaneous. Posttraumatic gas gangrene accounts for 60% of the overall incidence; most cases involve automobile collisions.[13]

From 1998-2002, C septicum was implicated in causing serious infections in recipients of contaminated musculoskeletal-tissue allografts. In addition, 5 pediatric patients who had hemolytic uremic syndrome (HUS) secondary to infection by Escherichia coli O157 were later infected by C septicum with fatal complications.[14] Recently, Clostridium sordellii, an uncommon human pathogen, caused fatal toxic shock syndrome, bacteremia, and extensive endometritis in 4 young women who underwent medical abortion with oral mifepristone and vaginal misoprostol.[15]

International

From April 2000 to June 2000, several users of injection drugs in Scotland, Ireland, and England developed serious clostridial infections (C novyi and C perfringens) complicated by a high mortality rate (97%). Most of these patients reported injecting heroin intramuscularly within the previous two weeks.[16]

With more than 200,000 liposuctions performed in Germany in 2003, several serious complications had been reported. Necrotizing fasciitis and gas gangrene were the most frequent, major and lethal complications observed in a review of 72 cases of complications caused by liposuction performed in Germany between 1998 and 2002.[17]

A tsunami ravaged Indonesia in December 2004 and killed more than 200,000 Indonesians. Soaking in contaminated water, several injured persons later died of tetanus or gas gangrene.

In May 2008, the Sichuan earthquake in China caused more than 70,000 deaths and approximately 400,000 injuries; several injured persons developed gas gangrene and later underwent amputations. Among 2131 survivors admitted to a public hospital in the Sichuan area, at least 19 patients (0.9%) developed gas gangrene .[5]

Mortality/Morbidity

Gas gangrene is undoubtedly an infection that carries a very high mortality rate. The reported mortality rates vary widely, with a rate of 25% in most recent studies. The mortality rate approaches 100% in individuals with spontaneous gas gangrene and in those in whom treatment is delayed.[18]

Sex

Gas gangrene has no reported sexual predilection, and the sex of the individual does not affect the outcome.

Age

Although age is not a prognostic factor in gas gangrene, advanced age and comorbid conditions are associated with a higher likelihood of mortality.

Previous
 
 
Contributor Information and Disclosures
Author

Hoi Ho, MD  Associate Dean for Faculty Affairs and Development, Professor, Department of Internal Medicine, Director, Center for Advanced Teaching and Assessment in Clinical Simulation (ATACS), Paul L Foster School of Medicine, Texas Tech University Health Sciences Center; Consulting Physician, University Medical Center

Hoi Ho, MD is a member of the following medical societies: Alpha Omega Alpha, American Association for the Advancement of Science, American College of Forensic Examiners, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Coauthor(s)

Juan B Figueroa-Casas, MD  Associate Professor, Division of Pulmonary and Critical Care Medicine, Texas Tech University Health Sciences Center at El Paso

Disclosure: Nothing to disclose.

David G Maxfield  Texas Tech University Health Sciences Center, Paul L Foster School of Medicine

David G Maxfield, is a member of the following medical societies: American College of Physicians, Congress of Neurological Surgeons, and Texas Medical Association

Disclosure: Nothing to disclose.

Lorenzo B Aragon, MD  Associate Professor, Department of Family Medicine, Paul L Foster Texas Tech University Health Sciences Center; Medical Director, Ambrosio Guillen Texas State Veterans Home

Lorenzo B Aragon, MD is a member of the following medical societies: American Academy of Family Physicians, American Medical Directors Association, Society of Teachers of Family Medicine, and Texas Medical Association

Disclosure: Nothing to disclose.

Enes Kanlic, MD  Professor, Department of Orthopedic Surgery, Texas Tech University Health Science Center

Disclosure: Stryker Honoraria Speaking and teaching

Specialty Editor Board

Pranatharthi Haran Chandrasekar, MBBS, MD  Professor, Department of Internal Medicine, Director of Infectious Disease Fellowship, Harper Hospital, Wayne State University School of Medicine

Pranatharthi Haran Chandrasekar, MBBS, MD is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Charles V Sanders, MD  Edgar Hull Professor and Chairman, Department of Internal Medicine, Professor of Microbiology, Immunology and Parasitology, Louisiana State University School of Medicine at New Orleans; Medical Director, Medicine Hospital Center, Charity Hospital and Medical Center of Louisiana at New Orleans; Consulting Staff, Ochsner Medical Center

Charles V Sanders, MD is a member of the following medical societies: Alliance for the Prudent Use of Antibiotics, Alpha Omega Alpha, American Association for the Advancement of Science, American Association of University Professors, American Clinical and Climatological Association, American College of Physician Executives, American College of Physicians, American Federation for Medical Research, American Foundation for AIDS Research, American Geriatrics Society, American Lung Association, American Medical Association, American Society for Microbiology, American Thoracic Society, American Venereal Disease Association, Association for Professionals in Infection Control and Epidemiology, Association of American Medical Colleges, Association of American Physicians, Association of Professors of Medicine, Infectious Disease Society for Obstetrics and Gynecology, Infectious Diseases Society of America, Louisiana State Medical Society, Orleans Parish Medical Society, Royal Society of Medicine, Sigma Xi, Society of General Internal Medicine, Southeastern Clinical Club, Southern Medical Association, Southern Society for Clinical Investigation, and Southwestern Association of Clinical Microbiology

Disclosure: Baxter International and Johnson & Johnson Royalty Other

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous coauthors Jeffrey P Nelson, MD; Miguel Angel Pena-Ruiz, MD; and Karl C Bentley, MS, to the development and writing of this article.

References
  1. Chapnick EK, Abter EI. Necrotizing soft-tissue infections. Infect Dis Clin North Am. Dec 1996;10(4):835-55. [Medline].

  2. Gawande A. Casualties of war--military care for the wounded from Iraq and Afghanistan. N Engl J Med. Dec 9 2004;351(24):2471-5. [Medline].

  3. Murray CK, Hsu JR, Solomkin JS, Keeling JJ, Andersen RC, Ficke JR. Prevention and management of infections associated with combat-related extremity injuries. J Trauma. Mar 2008;64(3 Suppl):S239-51. [Medline].

  4. U.S. casualty status. Department of Defense, 2004. Available at http://www.defenselink.mil/news/casualty.pdf.

  5. Wang Y, Hao P, Lu B, Yu H, Huang W, Hou H, et al. Causes of infection after earthquake, China, 2008. Emerg Infect Dis. Jun 2010;16(6):974-5. [Medline]. [Full Text].

  6. De A, Varaiya A, Mathur M, Bhesania A. Bacteriological studies of gas gangrene and related infections. Indian J Med Microbiol. Jul-Sep 2003;21(3):202-4. [Medline]. [Full Text].

  7. Hart GB, Lamb RC, Strauss MB. Gas gangrene. J Trauma. Nov 1983;23(11):991-1000. [Medline].

  8. Nichols RL, Smith JW. Anaerobes from a surgical perspective. Clin Infect Dis. May 1994;18 Suppl 4:S280-6. [Medline].

  9. Knapp O, Maier E, Mkaddem SB, Benz R, Bens M, Chenal A, et al. Clostridium septicum alpha-toxin forms pores and induces rapid cell necrosis. Toxicon. Jan 2010;55(1):61-72. [Medline].

  10. Oda M, Kihara A, Yoshioka H, Saito Y, Watanabe N, Uoo K. Effect of erythromycin on biological activities induced by clostridium perfringens alpha-toxin. J Pharmacol Exp Ther. Dec 2008;327(3):934-40. [Medline].

  11. Ohtani K, Hirakawa H, Tashiro K, Yoshizawa S, Kuhara S, Shimizu T. Identification of a two-component VirR/VirS regulon in Clostridium perfringens. Anaerobe. Jun 2010;16(3):258-64. [Medline].

  12. Stevens DL, Musher DM, Watson DA, et al. Spontaneous, nontraumatic gangrene due to Clostridium septicum. Rev Infect Dis. Mar-Apr 1990;12(2):286-96. [Medline].

  13. Brown PW, Kinman PB. Gas gangrene in a metropolitan community. J Bone Joint Surg [Am]. Oct 1974;56(7):1445-51. [Medline].

  14. Barnham M, Weightman N. Clostridium septicum infection and hemolytic uremic syndrome. Emerg Infect Dis. Apr-Jun 1998;4(2):321-4. [Medline]. [Full Text].

  15. Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, Van Meter SH, et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med. Dec 1 2005;353(22):2352-60. [Medline].

  16. McGuigan CC, Penrice GM, Gruer L, Ahmed S, Goldberg D, Black M. Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol. Nov 2002;51(11):971-7. [Medline].

  17. Lehnhardt M, Homann HH, Daigeler A, Hauser J, Palka P, Steinau HU. Major and lethal complications of liposuction: a review of 72 cases in Germany between 1998 and 2002. Plast Reconstr Surg. Jun 2008;121(6):396e-403e. [Medline].

  18. Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJ. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. Nov 15 2005;41(10):1373-406. [Medline].

  19. Larson CM, Bubrick MP, Jacobs DM, West MA. Malignancy, mortality, and medicosurgical management of Clostridium septicum infection. Surgery. Oct 1995;118(4):592-7; discussion 597-8. [Medline].

  20. Chen E, Deng L, Liu Z, Zhu X, Chen X, Tang H. Management of gas gangrene in Wenchuan earthquake victims. J Huazhong Univ Sci Technolog Med Sci. Feb 2011;31(1):83-7. [Medline].

  21. Zacharias N, Velmahos GC, Salama A, Alam HB, de Moya M, King DR. Diagnosis of necrotizing soft tissue infections by computed tomography. Arch Surg. May 2010;145(5):452-5. [Medline].

  22. Hopkins KL, Li KC, Bergman G. Gadolinium-DTPA-enhanced magnetic resonance imaging of musculoskeletal infectious processes. Skeletal Radiol. Jul 1995;24(5):325-30. [Medline].

  23. Butcher CH, Dooley RW, Levitov AB. Detection of subcutaneous and intramuscular air with sonography: a sensitive and specific modality. J Ultrasound Med. Jun 2011;30(6):791-5. [Medline].

  24. Majeski J, Majeski E. Necrotizing fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J. Nov 1997;90(11):1065-8. [Medline].

  25. Ustin JS, Malangoni MA. Necrotizing soft tissue infections. Crit Care Med. Apr 28 2011;[Medline].

  26. Stevens DL, Maier KA, Laine BM, Mitten JE. Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. J Infect Dis. Feb 1987;155(2):220-8. [Medline].

  27. Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG, Rosenblatt JE. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrob Agents Chemother. Apr 2001;45(4):1238-43. [Medline].

  28. Khanna N. Clindamycin-resistant Clostridium perfringens cellulitis. J Tissue Viability. Aug 2008;17(3):95-7. [Medline].

  29. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. Mar 8 2001;344(10):699-709. [Medline].

  30. [Best Evidence] Abraham E, Laterre PF, Garg R, Levy H, Talwar D, Trzaskoma BL. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. Sep 29 2005;353(13):1332-41. [Medline].

  31. Stevens DL, Bryant AE, Adams K, Mader JT. Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. Clin Infect Dis. Aug 1993;17(2):231-7. [Medline].

  32. Brown DR, Davis NL, Lepawsky M, et al. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. May 1994;167(5):485-9. [Medline].

  33. George ME, Rueth NM, Skarda DE, Chipman JG, Quickel RR, Beilman GJ. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt). Feb 2009;10(1):21-8. [Medline].

  34. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. Jun 20 1996;334(25):1642-8. [Medline].

  35. Stevens DL, Troyer BE, Merrick DT, et al. Lethal effects and cardiovascular effects of purified alpha- and theta- toxins from Clostridium perfringens. J Infect Dis. Feb 1988;157(2):272-9. [Medline].

Previous
Next
 
A patient developed gas gangrene after injecting cocaine. Clostridium septicum was isolated in both blood and wound cultures.
Gas feathering in the arm soft tissue of a patient with gas gangrene.
Extension of gas gangrene to the chest wall despite initial debridement.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.